cyclosporine has been researched along with Dementias, Transmissible in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bejerano-Sagie, M; Ben-Gedalya, T; Cohen, E; Kaganovich, D; Karpuj, MV; Kogan, NM; Lyakhovetsky, R; Yedidia, Y | 1 |
| Dohgu, S; Higuchi, S; Katamine, S; Kataoka, Y; Naito, M; Niwa, M; Sawada, Y; Shirabe, S; Takata, F; Tsuruo, T; Yamauchi, A | 1 |
2 other study(ies) available for cyclosporine and Dementias, Transmissible
| Article | Year |
|---|---|
Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Crystallins; Cyclosporine; HSP70 Heat-Shock Proteins; Humans; Inclusion Bodies; Multiprotein Complexes; Prion Diseases; Prions; Proteasome Endopeptidase Complex; Protein Folding; Ubiquitin; Ubiquitinated Proteins | 2011 |
Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cation Transport Proteins; Cell Line; Cell Membrane; Cell Polarity; Cimetidine; Cyclosporine; Endothelial Cells; Fluorescein; Membrane Potentials; Mice; Prion Diseases; Quinacrine; Tetraethylammonium; Verapamil | 2004 |